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Nosocomial infections have become alarming with the increase of multidrug-resistant
bacterial strains of Acinetobacter baumannii. Being the causative agent in ∼80% of
the cases, these pathogenic gram-negative species could be deadly for hospitalized
patients, especially in intensive care units utilizing ventilators, urinary catheters,
and nasogastric tubes. Primarily infecting an immuno-compromised system, they
are resistant to most antibiotics and are the root cause of various types of
opportunistic infections including but not limited to septicemia, endocarditis, meningitis,
pneumonia, skin, and wound sepsis and even urinary tract infections. Conventional
experimental methods including typing, computational methods encompassing
comparative genomics, and combined methods of reverse vaccinology and proteomics
had been proposed to differentiate and develop vaccines and/or drugs for several
outbreak strains. However, identifying proteins suitable enough to be posed as drug
targets and/or molecular vaccines against the multidrug-resistant pathogenic bacterial
strains has probably remained an open issue to address. In these cases of novel protein
identification, the targets either are uncharacterized or have been unable to confer the
most coveted protection either in the form of molecular vaccine candidates or as drug
targets. Here, we report a strategic approach with the 3,766 proteins from the whole
genome of A. baumannii ATCC19606 (AB) to rationally identify plausible candidates and
propose them as future molecular vaccine candidates and/or drug targets. Essentially,
we started with mapping the vaccine candidates (VaC) and virulence factors (ViF) of A.
baumannii strain AYE onto strain ATCC19606 to identify them in the latter. Wemove on to
build small networks of VaC and ViF to conceptualize their position in the network space
of the whole genomic protein interactome (GPIN) and rationalize their candidature for
drugs and/or molecular vaccines. To this end, we propose new sets of known proteins
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unearthed from interactome built using key factors, KeF, potent enough to compete with
VaC and ViF. Our method is the first of its kind to propose, albeit theoretically, a rational
approach to identify crucial proteins and pose them for candidates of vaccines and/or
drugs effective enough to combat the deadly pathogenic threats of A. baumannii.
Keywords: Acinetobacter baumannii, nosocomial infection, vaccine candidates, drug targets, network analysis
INTRODUCTION
Nosocomial or hospital-acquired infections are among the
multitude of diseases caused by the opportunistic pathogen
Acinetobacter baumannii, one of the world’s six most important
multidrug-resistant (MDR) microorganisms identified in
hospitals (Talbot et al., 2006; Lin and Lan, 2014). While critically
ill patients in the intensive care unit (ICU) accounted for up
to 20% of ventilator-associated pneumonia and bloodstream
infections with A. baumannii (Fournier and Richet, 2006;
Vincent et al., 2009), the mortality rates might reach up to 35%
along with endocarditis, meningitis, skin and wound sepsis, and
even urinary tract infections for immunosuppressive patients
(Lin and Lan, 2014; Darvishi, 2016). The cases for treatment
are complicated due to the fact that the severity of the infection
depends on the site and the patient’s susceptibility to such
diseases (Antunes et al., 2014). Moreover, there exist numerous
natural reservoirs for A. baumannii including natural and
agricultural soil, vegetables, aquaculture, and other inanimate
objects outside the hospital environment (Eveillard et al., 2013).
The complications, resulting in an array of diseases caused
by A. baumannii, arise from a plethora of virulence factors
used by the pathogen to access and colonize the host system.
These include, but are obviously not limited to, porins,
capsular polysaccharides, lipopolysaccharides, phospholipases,
outer membrane vesicles (OMVs), metal acquisition systems,
and protein secretion systems (Lee et al., 2017). Besides
these, β-lactamases acquisition, eﬄux pumps up-regulation,
aminoglycosides modification, target sites alteration, and
permeability defects are the crucial factors guiding the
mechanism of antibiotic resistance conferred by this pathogen
(Lee et al., 2017). Further threats of infection arise from
colonization outside the human host, mainly on medical devices,
through the mechanism of biofilm production involving the
associated pathways, proteins, secretion systems, and quorum
sensing (Perez et al., 2007). With such a robust antibiotic
resistance mechanism entailing a barrage of proteins comprising
the host invading machinery, A. baumannii has been able to
confer extensive drug resistance (XDR). In fact, such ability
has gone to the extent of evading almost every new-generation
antibiotic, including carbapenems, which used to be prescribed
to treat MDR organismal infections (Viehman et al., 2014).
To cater to the need of addressing the urgent and pressing
issues of antibiotic threats, vaccine development has been
resorted to as one of the cost-effective and most promising
strategies to prevent infections. This is due to the fact that
inactivated whole cells and attenuated strains are able to
elicit antibodies against multiple surface proteins, which can
be utilized in the form of vaccines, to combat the antibiotic
threats. In fact, efforts have been tested to utilize only
parts of the pathogen without the administration of whole
organisms. Thus, vaccines comprising multiple proteins of the
bacterial outer membrane complex (OMC), OMVs, OmpA,
auto-transporter (Ata), biofilm-associated protein (Bap), K1
capsular polysaccharide, and poly-N-acetyl-β-(1-6)-glucosamine
(PNAG) have been shown to elicit antibodies and to induce
protective immunity against infection, thereby giving promising
results in early human clinical trials (Bertot et al., 2007;
Fransen et al., 2007; Chiang et al., 2015). Moreover, recent
studies to determine potential vaccine targets have delineated a
combinatorial approach of in silico prediction tools with reverse
vaccinology through comparative genome analysis and in vitro
proteomics (Moriel et al., 2013; Singh et al., 2017). For instance,
in silico analysis in A. baumannii helped the identification
of a highly conserved outer membrane protein with β-barrel
assembly, BamA, as the potential target for vaccine (Singh et al.,
2017). However, the advent of new and emerging XDR strains
of A. baumannii, which possibly arises from immune selection,
might lead to antigen sequence variability and a down-regulation
of the target antigens, thereby conferring poor “cross-protective
efficacy” (Chiang et al., 2015). Therefore, the identification
of potential antigens, expressed by the new and emerging A.
baumannii strains during infections, still keeps the issue quite
complex to be addressed.
Simplifying the complexity of diseases, caused by such XDR
pathogens like A. baumannii, is thus challenging. Therefore, to
unearth plausible antigenic proteins, potential enough to elicit an
antibody response, a detailed analysis of the complex interaction
of the proteins, involved in the disease phenomenon, might
be helpful. Earlier attempts to computationally analyze such
protein interaction networks or interactomes (PIN) of infectious
diseases mostly focused on network centrality parametric values
for the identification of candidate drug targets (Lahiri et al., 2014;
Pan et al., 2015). Generally, in biological networks, centrality
measures of degree (DC), betweenness (BC), closeness (CC), and
eigenvector (EC) have been used extensively (Jeong et al., 2001;
Lahiri et al., 2014; Pan et al., 2015). While DC gives a very
basic understanding of the number of interacting partners of a
particular protein, EC relates to the essential proteins interacting
with other crucial partners in the disease phenomenon (Lahiri
et al., 2014). Besides BC, EC has been shown to be a good
target for drugs, albeit theoretically for infectious diseases and
utilized in the identification of side effect-free drug targets of
idiopathic diseases like cancer (Lahiri et al., 2014; Pan et al., 2015;
Ashraf et al., 2018). However, in order to gain an insight into the
global scenario of the disease complexity, the PIN needs to be
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inspected thoroughly for an effective analysis, potential enough
to be translational in nature. Thus, the whole genome protein
interactome (GPIN) has been utilized to prune and decompose
to obtain a core of highly interacting proteins through the k-
core analysis approach (Seidman, 1983). This coupled with the
functional module-based cartographic analyses of the global
network (Guimerà and Nunes Amaral, 2005a) has already been
adopted to theoretically identify potential role players in bacterial
infectious diseases (Pawar et al., 2017, 2018).
In this study, we have similarly delineated the relevance of
the aforementioned centrality parametric measures for PIN of
the claimed vaccine candidates and virulence factors (Moriel
et al., 2013) of A. baumannii, namely, VaCAB and ViFAB. To
this end, we have analyzed KeFAB, the PIN of key factors
responsible for virulence and pathogenicity of A. baumannii
(Chen et al., 2015). The top rankers of these three PINs were
mapped onto the GPIN of A. baumannii to unravel their position
in the network space and rationalize their candidature for
drugs and/or molecular vaccines compared to our own sets of
proposed candidates for vaccines. We consolidate our findings
by the antigenic potential of these proteins along with their
active sites for drug targets. In summary, we analyze the PIN
of different relevant pathogenic proteins of A. baumannii to
identify the plausible potential candidates for vaccines and/or
drugs targets.
MATERIALS AND METHODS
Acronyms and Terms Utilized
The present study on A. baumannii comprises a conglomerate
of several terms pertaining to graph theory in general and
network biology in particular. Table 1 lists them all in a
comprehensive manner with an expansion of the acronym,
where applicable, followed by a short description of the terms
for the ease of reference of a broad interdisciplinary range
of readers.
Dataset Collection and Processing
Datasets for A. baumannii proteins were collected in different
ways. The focus was given for either the strains AYE or
ATCC17978, having either substantial reports or evidences for
causing MDR. For the strain AYE, 168 proteins mentioned in the
Supplementary Data 2 byMoriel et al. (2013) were collected and
categorized as vaccine candidates (VaC, Supplementary Data 1)
while 124 from Supplementary Datas 3–5 reported by
the same group were collated as virulent factors (ViF,
Supplementary Data 2). Other proteins were collected using
keywords used by default for the available strains of ATCC17978
and AYE in VFDB (Chen et al., 2015). To this end, using the
same keywords, further proteins of these strains were collected
through direct literature search and the sequences of all these
were retrieved from UniProt database (Apweiler et al., 2004).
The last category proteins from VFDB, UniProt, and literature
were parked under key factors (KeF, Supplementary Data 3).
The counts of identifiers (IDs) for the various KeF proteins
were 973 for ATCC17978, 92 for AYE, and 24 for no IDs found
in the literature. Nine of these IDs, belonging to t-RNA, were
eliminated, leaving a final total of 1,078 KeF (Figure 1).
The datasets of the aforementioned VaC, ViF, and KeF
proteins were converted into the counterparts of the
corresponding A. baumannii strain ATCC19606, due to the
reason of non-availability of ATCC17978 and AYE strains in the
STRING 10.5 biological meta-database of protein interaction
(Szklarczyk et al., 2016). A FASTA file containing a total of 3,376
protein sequences, downloaded from STRING for A. baumannii
strain ATCC19606, was used as a database for standalone BLAST
during mapping of the sequences of strain AYE onto strain
19606. Standalone BLAST is a non-graphic user interface version
of BLAST that runs on command lines in Linux operating system
(OS) and allows execution of BLAST locally on such OS for
sequence alignment. The execution of such BLAST, returned
2,111 and 1,676 hits for VaC and ViF, respectively. A filtering
of the topmost ones with the highest percentage of identities
from these hits returned 168 and 123 proteins, respectively, of
the strain 19606. A further threshold cutoff of 99–100% identity
was set to select out the identical proteins of strain AYE in 19606
for the next set of analysis, leaving out other ambiguous ones
(duplicates and/or percentage-wise less identical) to obtain 79
VaC and 78 ViF proteins of strain 19606. Similar approaches
were adopted for selecting out the KeF proteins of the strain
19606 from those of the strains ATCC17978 and AYE. For
this, 1,078 KeF protein sequences were executed in standalone
BLAST to yield a total of 15,793 hits, from which the top-ranked
1,075 proteins, with highest percentage identity, were selected
out. Final cutoff of 99–100% identity was used to remove
ambiguous ones and duplicates to obtain 640 IDs for further
processing (Figure 1).
Submission of these mapped proteins of ATCC19606 into
STRING helped the retrieval of protein interaction datasets
having the default medium (0.4) level confidence upon the
interaction (period of access: August to September 2018). The
detailed protein links file containing the interaction datasets
for the whole genome of A. baumannii strain ATCC19606 was
retrieved for the accession number 575584 in STRING. All
interaction datasets for each category of VaC, ViF, and KeF
proteins, hereafter used for PIN construction, have been listed in
Supplementary Datas 1–3.
Interactome Construction
After the removal of duplicate interactions, all individual
interaction data obtained as above were imported for
construction and visualization of the small PINs (SPINs),
which were named VaCAB, ViFAB, and KeFAB, and the
whole genome PIN named GPIN, using Cytoscape version
3.6.0 (Shannon et al., 2003) and Gephi 0.9.2 (Bastian et al.,
2009) (Figure 2; Supplementary Datas 1–3: Sheets 5–7). All
interactomes were considered to be non-directional in nature to
represent undirected graphs as G = (V, E), where V are finite set
of vertices and E are edges in which e = (u,v) connecting two
vertices (nodes), u and v, or proteins in the present context. Thus,
the degree, d (v), indicates the number of interactions (physical
and functional) a protein has with other proteins (Diestel, 2000).
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TABLE 1 | The acronyms and terms used in the present study.
Acronyms/Terms Description
VaC Vaccine Candidates; proteins reported by Moriel et al. from Acinetobacter baumannii strain AYE and ATCC17978
ViF Virulent Factors; proteins reported by Moriel et al. from A. baumannii strain AYE and ATCC17978
KeF Key Factors; proteins retrieved from various databases and literature survey from strain AYE and ATCC17978 using common terms
related to virulence
VFDB Virulent Factors Database; database of several bacteria listing the known and/or predicted virulent factors as per literature
STRING Search Tool for the Retrieval of Interacting Genes/Proteins; meta-database listing known and predicted protein–protein interactions
from biological organisms
Cytoscape/Gephi Interacting Software for visualizing node and edges of a graph and integrating them together
PIN Protein Interaction Network; interaction pattern of proteins in a graphical form giving a network of nodes and edges
Interactome A network of interacting entities; in the present study, this refers to Protein Interactome or PIN
Interactors The molecules interacting in a network; in the present study, these are proteins interacting with VaC, ViF, or KeF
VaCAB VaC PIN of A. baumannii; interactome of VaC with their interactors of strain ATCC19606 retrieved from STRING and visualized
through Cytoscape/Gephi
ViFAB ViF PIN of A. baumannii; interactome of ViF with their interactors of strain ATCC19606 retrieved from STRING and visualized through
Cytoscape/Gephi
KeFAB KeF PIN of A. baumannii; interactome of KeF with their interactors of strain ATCC19606 retrieved from STRING and visualized
through Cytoscape/Gephi
SPIN Small PIN of A. baumannii; this refers to VaCAB/ViFAB/KeFAB of A. baumannii strain ATCC19606
GPIN Genomic PIN of A. baumannii; interactome of the total number of proteins of whole genome of A. baumannii strain ATCC19606
retrieved from STRING and visualized through Cytoscape/Gephi
Network Analyser Java Plug-in for Cytoscape for graph theoretical analysis of the network of nodes and edges
CytoNCA Cytoscape Network Centrality Analyser; Cytoscape Java Plug-in for graph theoretical analysis of the network of nodes and edges
Centrality Measures Graph theoretical measures for assessing the central character of nodes
BC/CC/DC/EC Betweenness/Closeness/Degree/Eigenvector centrality measures; reflect measures for nodes of central
passage/proximity/connectivity/weightage, respectively
k-Core Maximally connected sub-graph of nodes having at least k-degree; achieved by gradually pruning all nodes of degree less than k
Modules Sub-graphs of nodes having common aspects with respect to common biological functions
Functional Connectivity Different classes of within-module and between-module connectivity
KFC An approach combining k-core, functional connectivity, and centrality measures
Standalone BLAST Offline Basic Local Alignment Search Tool; this comprises a downloadable version of the sequence alignment tool that can be
installed locally on system and can be used with command lines to find the match/mismatch/gap between the given sequences
COG Cluster of Orthologous Groups; similar groups of proteins having related functions
PIN Analyses
SPIN
Each of the constructed three SPINs were subsequently analyzed
utilizing BC, CC, DC, and EC measures of centrality, commonly
applied to biological networks (Pavlopoulos et al., 2011)
(Supplementary Datas 1–3). This was done with the Cytoscape
integrated java plugins, namely, Network Analyzer andCytoNCA
(Assenov et al., 2007; Tang et al., 2015), utilizing the edge weights
as the combined scores obtained from different parameters in
STRING. These combined scores, which range from 0 to 1,
generally convey the confidence of the protein’s interaction with
level of parametric evidences from gene neighborhood, gene
fusion, gene co-occurrence, gene co-expression, experiments,
annotated pathways, and text mining. Using the top 15 proteins
appearing for each measures of analysis as mentioned above,
a commonality of the proteins for all centrality measures was
observed through Venny 2.1 (Oliveros, 2007–2015) (Figure 3).
GPIN
The whole genome protein interaction network, GPIN, was
analyzed by MATLAB version 7.11 (MATLAB Statistics Toolbox
Release, 2010). An idea of the simplest of the technical
aspects of the GPIN, i.e., the distributions of network degree
(k), was obtained by plotting it against the Complementary
Cumulative Distribution Function (CCDF) (Figure 4A). A k-
core analysis of the whole genome was done by a network
decomposition method that produces a gradually increasing
cohesive sequence of sub-graphs and reveals the number
of proteins having at least k-degree classified in K-shell as
per their interacting patterns (Figures 4B,C) (Seidman, 1983).
Further knowledge of the connectivity and participation of
each protein, with respect to their functions, was obtained
through analysis of the cartographic representation of the
network topology that plots the within-module degree z
score of the protein against its participation coefficient, P
(Figure 5) (Guimerà and Amaral, 2005b). The participation
of each protein in a modular network, sharing common
biological function, gives rise to a concept of functional module
having high intra-connectivity and sparse inter-connectivity
(Vella et al., 2018). Calculations of such functional modules
as per Rosvall method (Rosvall and Bergstrom, 2011) led
to a major classification of the proteins of GPIN into
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FIGURE 1 | The flow chart for the whole process of the present study.
non-hub and hub nodes, each having further sub-classes.
These are ultra-peripheral (R1), peripheral (R2), non-hub
connector (R3), and non-hub kinless (R4) for the former
while provincial (R5), connector (R6), and kinless (R7) for
the latter categories (Guimerà and Amaral, 2005b) (Figure 5;
Supplementary Data 4).
Vaccine and/or Drug Candidature
Prediction
The network analyzed and shortlisted VaC, ViF, and KeF proteins
along with their interactors from the three SPINs, namely,
VaCAB, ViFAB, and KeFAB, were subjected to further analyses
for predicting the plausible vaccine and/or drug candidates.
To this end, the indispensable proteins of the GPIN were also
taken into consideration as per the KFC method described
by Ashraf et al. (2018). All such proteins were explored
for their cellular localization, signal peptide prediction, COG
classification, antigenic site prediction, followed by active site
prediction. Cellular localization was analyzed by PSORTb v3.0.2
(Yu et al., 2010). Location of signal peptides was predicted
using the server called SignalP 4.1 Server (Petersen et al.,
2011). Lipoprotein signal peptides were predicted using the
LipoP 1.0 Server (Juncker et al., 2003). For uncharacterized
proteins, functional annotation with classification was done
through the WebMGA server (Wu et al., 2011). Such COG
classification from WebMGA was performed for all proteins,
however, even if they are characterized, to maintain unanimity of
comparison. To predict the antigenic potential of the candidate
proteins, epitope prediction was done through the immune
epitope database (IEDB) resource utilizing Bepipred Linear
Epitope Prediction and maintaining a threshold cutoff of 0.75
for increased sensitivity (Vita et al., 2014). Furthermore, without
any solved X-ray crystallographic or NMR 3D structures for the
selected proteins, they were homology modeled and validated
to pursue active site prediction studies. We have used Phyre2
(Kelley et al., 2015) and SWISS MODEL (Schwede et al., 2003)
protein modeling servers to generate the structures and the
integrated Procheck server in the latter, to evaluate them through
Ramachandran plot, Q mean score, and z score. To identify
the best structure of the different models generated by the
abovementioned servers, we have performed consensus studies.
These consensus models were finally utilized to determine the
active sites or binding pockets of the selected proteins by the
CASTp server (Computer Atlas of Surface Topology of protein)
(Dundas et al., 2006). A comparative account of the results
obtained from this section of the analysis is shown in Table 7.
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FIGURE 2 | The three SPINs and GPINs of A. baumannii reflecting the degree of connectivity. SPINs are represented in blue spheres connected through blue-colored
curved lines for (A) VaCAB, having vaccine candidates; (B) ViFAB, with virulent factors; and (C) KeFAB, with key factors each with their interactors. (D) GPIN with
proteins represented in black spheres connected with black curved lines to form the interactome.
FIGURE 3 | Venn diagram representation for the top-ranking network centrality measures of SPIN and GPIN of A. baumannii. (A,B) VaCAB, (C,D) ViFAB, (E,F)
KeFAB, and (G) GPIN. Measures of four types of centrality are from CytoNCA and three types are from Network Analyzer. BC, CC, DC, and EC denote betweenness
centrality, closeness centrality, degree centrality, and eigenvector centrality, respectively.
Interactor-Free Candidature Analyses
In order to determine the important vaccine candidates among
a barrage of proteins proposed by Moriel et al. (2013), filtration
was used to remove the influence of the interactors on the actual
candidates upon their ranking. For the same, we have initially
merged the VaCAB and ViFAB together, having their individual
centrality-based analyzed data. Thereafter, the VaC and ViF
interactors, of the respective PIN, were removed, leaving behind
the actual candidates. As the PINs (VaCAB and ViFAB) were
constructed from STRING data using the strain ATCC19606, we
mapped back the centrality measures of the total VaC and ViF
proteins onto the AYE strain of A. baumannii. This was followed
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FIGURE 4 | Network topological measures for the set of proteins from the GPIN of A. baumannii. (A) The degree distribution, (B) k-core distribution, and (C) K-shell
sizes. CCDF denotes Complementary Cumulative Distribution Function.
FIGURE 5 | Cartographic representation for the set of classified proteins from the GPIN of A. baumannii. Designated quadrants from R1 to R7 (in random colors)
comprise nodes in each representing different classes of proteins. Selected Vaccine Candidates, VaC (V), Virulent Factors, ViF (F), and Key Factors, KeF (K) proteins
from network centrality analyzed SPIN (Small PIN) are mapped onto different quadrants as deemed fit in GPIN (Genome PIN). ∧ and * represent proteins shared
between different centralities only and those also between different categories, respectively.
by assigning the localization status of the total set of candidate
proteins through the usage of PSORTb. Sorting was done based
on localization followed by descending order of the centrality
measures. Top five rankers, in each case, were used for creating
a Venn diagram to find out the most promising candidates from
the intersection of the centrality measures (Figure 1).
RESULTS
The Candidate Proteins
In order to the identify the potential molecular vaccine
candidates and drug targets of MDR A. baumannii, we have
started with the available pathogenic strains, namely, AYE
and ATCC17978, to accumulate the proclaimed proteins in
categories of VaC, ViF, and KeF with counts of 168, 124, and
1,078, respectively (Supplementary Datas 1–3: Sheet 1). As these
strains are not enlisted in the protein interaction database,
STRING, we had to find the real counterparts of these proteins,
from the only listed strain ATCC19606. An initial processing
of the data through standalone blast from the total protein
sets of ATCC19606 yielded 168, 123, and 1,075 VaC, ViF,
and KeF candidates, respectively (Supplementary Datas 1–3:
Sheet 3), which were further filtered for an exact match of
99–100% to result in 79, 78, and 640 proteins, respectively
(Supplementary Datas 1–3: Sheet 4). Thus, all the candidate
proteins were mapped onto ATCC19606 from other pathogenic
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strains. All data, hereafter, refer to strain ATCC19606 only, unless
otherwise stated.
The Three Individual SPINs
To identify the crucial candidates among the three
aforementioned sets of VaC, ViF, and KeF proteins of A.
baumannii, we have taken an approach of building three
different SPINs, each with its respective set of interaction
data (Figure 2; Supplementary Datas 1–3: Sheets 5–7). Upon
analyzing these SPINs through the Cytoscape plugins CytoNCA
and Network Analyzer, the top rank holders as per each centrality
measures are recorded (Supplementary Datas 1–3: Sheets 8–11),
indicating their importance. A combined result from both the
plugins are presented in Table 2, wherein protein entries are
represented by their NCBI gene accession numbers with the
suffix “HMPREF0010_” being replaced by “AB_” for the ease
of further use. It is to be noted that there are overlaps of these
protein entries across the different centrality measures and/or
the different categories of VaCAB, ViFAB, and KeFAB. An
overlap of the proteins across the measures within a particular
category is represented by a “caret” (∧) notation while that from
cross-categories is denoted with an “asterisk” (∗). For instance,
the protein AB_03493 is associated with the VaCAB category
and is represented with V1∗, due to its presence in the category
of ViFAB (BC measure), despite its presence in two measures of
BC and DC of VaCAB. On the contrary, AB_1947 is present in
the BC, CC, and DC categories of ViFAB only and is represented
by F5∧. The numbers of the proteins to denote such overlaps are
put randomly, however, and do not indicate the actual ordering
of the rank as depicted in Table 2. Each one of such overlapping
proteins has been indicated in bold to stand out from the rest in
the same measures and/or categories and has been utilized for
further mapping in the whole genome context later (Figure 5).
It is important to note that there are more overlaps between
the VaCAB and ViFAB categories of proteins as indicated by
the asterisk in the entries. On the contrary, proteins of KeFAB
tend to have much fewer overlaps among other categories. The
numbers of the top-ranking proteins from each of the categories
and measures of centralities and their overlaps are reflected with
Venn diagrams (Figure 3). The functions of these proteins, taken
from UniProt, reflect those that have been mostly characterized,
with some having proven and eminent roles as vaccine and drug
targets (Supplementary Datas 1–3: Sheet 12).
Despite the overview obtained about the importance of the
proteins from a comparative account within and between each of
the aforementioned categories of VaCAB, ViFAB, and KeFAB, it
is to be noted that these PINs are a mixture of the actual VaC, ViF,
and KeF proteins along with their interactors that were extracted
from STRING. Interestingly, of the 15 top rank holders of each
category of PIN, the actual proteins were 9, 3, 7, and 1 as per
BC, CC, DC, and EC measures of VaCAB, and the rest were their
interactors. Similarly, for ViFAB, the actual VaC proteins were
6, 6, 3, and 1 for the same measures, respectively, as mentioned
above. For KeFAB, however, the numbers of KeF proteins were
almost the same throughout, being 4, 5, 5, and 5 for BC, CC, DC,
and EC, respectively (Table 3). However, to decipher the effective
drug or a vaccine candidate from the global perspective of the
whole genome, the total sets of proteins interacting in the whole
genome of A. baumannii (GPIN) were analyzed as described in
the next section.
The Complete GPIN
In an attempt to project the most probable candidates for
vaccines and drug targets, we have further explored the GPIN.
GPIN, built from the theoretically predicted and empirically
found physical and functional interactions, was analyzed for
its degree distribution in general and k-core distribution in
particular. With an exponential curve for the cumulative degree
distribution frequency (CCDF), the non-linear preferential
attachment nature was evident (Figure 4A) (Vázquez, 2003).
To this end, an idea of the important proteins forming the
core of the genome was obtained through the k-core network
decomposition. The shell size of the 165th innermost core had
a conglomerate of 494 proteins (Figures 4B,C).
We have started analyzing the GPIN with the four common
centrality measures as mentioned for SPIN (Table 2). A closer
look at the top 15 from each measure reflects proteins mostly
from the categories of KeF, two of which have overlaps with
the ViFAB category (F1 and F2, Table 2). Around two-thirds
of the top-ranking positions in DC are occupied by KeFAB
proteins, while 99% of the top 15 EC measures comprise the
KeFAB categories.
A detailed k-core analysis of the different proteins as per
the centrality measures revealed other important facts. The
numbers of VaCAB proteins belonging to the innermost core
are 2, 3, 7, and 12 as per the top rank holders of BC, CC, DC,
and EC measures (Table 3). Of these, the numbers of VaC
proteins are 1, 1, 2, and 1 as per the same measures while the
rest are their interactors (Table 3). This analysis filters out
HMPREF0010_01334 as per the BC, CC, and DC measure
overlaps and HMPREF0010_02233 as per EC, to be in the
innermost core of the whole genome from the proclaimed VaC
proteins. For the ViFAB proteins, 6, 10, 14, and 14 proteins,
respectively, for BC, CC, DC, and EC measures belong to the
165th core, of which only 1, 2, 2, and 1, respectively, are the VaC
proteins while the rest are their interactors (Table 3). This filters
out HMPREF0010_03351 from BC, CC, and DC overlaps, while
the new candidates HMPREF0010_01731, HMPREF0010_02683,
and HMPREF0010_01948 stand out from CC, DC, and EC,
respectively. The picture becomes different when it comes to the
KeFAB where CC, DC, and EC all had only 165th core proteins
from the top rankers while BC reflected 14 of them. Moreover,
the actual KeF candidates are more in this PIN compared to the
VaC and ViF proteins. The analysis filters out 4, 5, 5, and 5 KeF
proteins from the BC, CC, DC, and EC measured top rankers
(Table 3). This brings forth the candidates HMPREF0010_03512
from BC and CC, HMPREF0010_00239 from CC and DC,
and HMPREF0010_00091 from DC and EC overlaps.
Moreover, three candidates, namely, HMPREF0010_02437,
HMPREF0010_01461, and HMPREF0010_02576, were unique
in having overlaps across CC, DC, and EC measures, while
HMPREF0010_01789 from EC and three candidates from
BC, namely, HMPREF0010_03553, HMPREF0010_01114, and
HMPREF0010_00382, were unique. It is important to note that
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TABLE 2 | The topmost proteins of A. baumannii SPIN and GPIN as per BC, CC, DC, and EC network centrality measures.
Network BC CC DC EC
SPIN
VaCAB AB_03493(V1*),
AB_01517(V2∧),
AB_01255(V3*),
AB_03704(V4∧),
AB_00353(V5*),
AB_01334(V6∧),
AB_00252,
AB_01118,
AB_01117,
AB_01710,
AB_00112,
AB_00698,
AB_00210,
AB_03124,
AB_00209
AB_03704(V4∧),
AB_00353(V5*),
AB_01334(V6∧),
AB_00811(V7∧),
AB_02146(V8∧),
AB_00805(V9∧),
AB_03351(V10*),
AB_02143(F6*),
AB_02888,
AB_02124,
AB_02677,
AB_02145,
AB_01785,
AB_03499,
AB_02178
AB_03493(V1*),
AB_01517(V2∧),
AB_01255(V3*),
AB_03704(V4∧),
AB_00353(V5*),
AB_01334(V6∧),
AB_00811(V7∧),
AB_02146(V8∧),
AB_00805(V9∧),
AB_03351(V10*),
AB_02233(V11∧),
AB_03186(V12*),
AB_03184(V13*),
AB_03185(V14∧),
AB_01388
AB_01255(V3*),
AB_02233(V11∧),
AB_03186(V12*),
AB_03184(V13*),
AB_03185(V14∧),
AB_01226,
AB_02909,
AB_02910,
AB_01257,
AB_00660,
AB_00760,
AB_01258,
AB_02683,
AB_00675,
AB_02914
ViFAB AB_01641(F1*),
AB_02522(F2*),
AB_03351(F3*),
AB_00353(F4*),
AB_01947(F5∧),
AB_02143(F6*),
AB_03493(V1*)
AB_01255(V3*),
AB_00113,
AB_01972,
AB_00354,
AB_01713,
AB_01724,
AB_02769,
AB_02820
AB_02522(F2*),
AB_03351(F3*),
AB_00353(F4*),
AB_01947(F5∧),
AB_02143(F6*),
AB_03184(F7*),
AB_02069(F8∧),
AB_00812,
AB_02142,
AB_01731,
AB_02888,
AB_01946,
AB_01248,
AB_02124,
AB_01647
AB_01641(F1*),
AB_02522(F2*),
AB_03351(F3*),
AB_00353(F4*),
AB_01947(F5∧),
AB_03184(F7*),
AB_02069(F8∧),
AB_02627(F9∧)
AB_03186(V12*),
AB_02909,
AB_01226,
AB_00660,
AB_02910,
AB_02683,
AB_01361
AB_02627(F9∧),
AB_02354,
AB_02629,
AB_01950,
AB_03765,
AB_00169,
AB_01359,
AB_01360,
AB_01656,
AB_01791,
AB_01948,
AB_01951,
AB_02545,
AB_02548,
AB_02626
KeFAB AB_01491(K1∧),
AB_01641(K2*),
AB_02522(K3*),
AB_03512(K4∧),
AB_03207(K5∧),
AB_00427,
AB_01800,
AB_03553,
AB_01281,
AB_02769,
AB_01114,
AB_00382,
AB_02314,
AB_03088,
AB_02152
AB_01491(K1∧),
AB_01641(K2*),
AB_02522(K3*),
AB_03512(K4∧),
AB_03207(K5∧),
AB_00239(K6∧),
AB_03022(K7∧),
AB_02437(K8∧),
AB_01461(K9∧),
AB_01350(K10∧),
AB_01047(K11∧),
AB_03233(K12∧),
AB_03046(K13∧),
AB_02576(K14∧),
AB_02252(K15∧)
AB_01491(K1∧),
AB_01641(K2*),
AB_00239(K6∧),
AB_03022(K7∧),
AB_02437(K8∧),
AB_01461(K9∧),
AB_01350(K10∧),
AB_01047(K11∧)
AB_03233(K12∧),
AB_03046(K13∧),
AB_02576(K14∧),
AB_02252(K15∧),
AB_01051(K16∧),
AB_01740(K17∧),
AB_00091(K18∧)
AB_01491(K1∧),
AB_03022(K7∧),
AB_02437(K8∧),
AB_01461(K9∧),
AB_01350(K10∧),
AB_01047(K11∧)
AB_03233(K12∧),
AB_03046(K13∧),
AB_02576(K14∧),
AB_02252(K15∧),
AB_01051(K16∧),
AB_01740(K17∧),
AB_00091(K18∧),
AB_01789,
AB_03031
GPIN
AB_01641(F1*/K2*),
AB_01590,
AB_02383,
AB_03076,
AB_03532,
AB_03595,
AB_02409,
AB_01611,
AB_01613,
AB_02391,
AB_03107,
AB_03129,
AB_01437,
AB_03092,
AB_00006
AB_00110,
AB_01918,
AB_02296,
AB_03731,
AB_03732,
AB_03317,
AB_03318,
AB_03726,
AB_02992,
AB_03666,
AB_02700,
AB_03651,
AB_02374,
AB_02371,
AB_02372
AB_01491(K1∧),
AB_01641(F1*/K2*),
AB_03512(K4∧),
AB_03207(K5∧),
AB_01461(K9∧),
AB_03233(K12∧),
AB_03046(K13∧),
AB_02576(K14∧),
AB_01740(K17∧),
AB_00091(K18∧),
AB_03659,
AB_03532,
AB_01651,
AB_00045,
AB_01281
AB_01491(K1∧),
AB_01641(F1*/K2*),
AB_02522(F2*/K3*),
AB_03512(K4∧),
AB_03207(K5∧),
AB_00239(K6∧),
AB_03022(K7∧),
AB_02437(K8∧),
AB_01461(K9∧),
AB_01350(K10∧),
AB_01047(K11∧),
AB_03233(K12∧),
AB_01051(K16∧),
AB_00091(K18∧),
AB_02769
The bold cased proteins are overlapping either within same categories (∧) or between others (*) in SPIN. Numbers are arbitrary.
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TABLE 3 | The innermost core proteins of VaCAB, ViFAB, KeFAB, and GPIN as per the four centrality measures.
Centrality
measures
Protein ID Protein
type
Core Protein ID Protein type Core Protein ID Protein
type
Core Protein ID Protein
type
Core
BC AB_03493 VaC 84 AB_01641 Interactor 165 AB_01491 Interactor 165 AB_01590 Genome 66
AB_01517 VaC 84 AB_02522 Interactor 165 AB_01641 Interactor 165 AB_02383 Genome 85
AB_01255 Interactor 165 AB_03351 ViF 165 AB_02522 Interactor 165 AB_03076 Genome 68
AB_03704 VaC 108 AB_00353 ViF 163 AB_03512 KeF 165 AB_03532 Genome 165
AB_00353 VaC 163 AB_01947 Interactor 165 AB_03207 Interactor 165 AB_01641 Genome 165
AB_01334 VaC 165 AB_02143 ViF 123 AB_00427 Interactor 165 AB_03595 Genome 162
AB_00252 VaC 68 AB_03493 ViF 86 AB_01800 Interactor 165 AB_02409 Genome 66
AB_01118 Interactor 70 AB_01255 Interactor 165 AB_03553 KeF 165 AB_01611 Genome 22
AB_01117 Interactor 90 AB_00113 Interactor 68 AB_01281 Interactor 165 AB_01613 Genome 66
AB_01710 VaC 91 AB_01972 Interactor 112 AB_02769 Interactor 165 AB_02391 Genome 161
AB_00112 Interactor 68 AB_00354 ViF 92 AB_01114 KeF 165 AB_03107 Genome 91
AB_00698 VaC 91 AB_01713 Interactor 151 AB_00382 KeF 165 AB_03129 Genome 74
AB_00210 Interactor 98 AB_01724 ViF 110 AB_02314 Interactor 165 AB_01437 Genome 30
AB_03124 Interactor 92 AB_02769 Interactor 165 AB_03088 Interactor 151 AB_03092 Genome 85
AB_00209 VaC 102 AB_02820 Interactor 147 AB_02152 Interactor 165 AB_00006 Genome 65
CC AB_03704 VaC 108 AB_02522 Interactor 165 AB_01491 Interactor 165 AB_00110 Genome 62
AB_00353 VaC 163 AB_03351 ViF 165 AB_01641 Interactor 165 AB_01918 Genome 5
AB_01334 VaC 165 AB_00353 ViF 163 AB_02522 Interactor 165 AB_02296 Genome 5
AB_00811 Interactor 124 AB_01947 Interactor 165 AB_03512 KeF 165 AB_03731 Genome 2
AB_02146 Interactor 112 AB_02143 ViF 123 AB_03207 Interactor 165 AB_03732 Genome 2
AB_00805 Interactor 104 AB_03184 Interactor 165 AB_00239 KeF 165 AB_03317 Genome 82
AB_03351 Interactor 165 AB_02069 Interactor 165 AB_03022 Interactor 165 AB_03318 Genome 76
AB_02143 Interactor 123 AB_00812 ViF 163 AB_02437 KeF 165 AB_03726 Genome 82
AB_02888 Interactor 123 AB_02142 ViF 134 AB_01461 KeF 165 AB_02992 Genome 6
AB_02124 Interactor 117 AB_01731 ViF 165 AB_01350 Interactor 165 AB_03666 Genome 4
AB_02677 Interactor 96 AB_02888 Interactor 123 AB_01047 Interactor 165 AB_02700 Genome 6
AB_02145 Interactor 104 AB_01946 Interactor 165 AB_03233 Interactor 165 AB_03651 Genome 2
AB_01785 Interactor 103 AB_01248 Interactor 165 AB_03046 Interactor 165 AB_02374 Genome 7
AB_03499 Interactor 131 AB_02124 Interactor 165 AB_02576 KeF 165 AB_02371 Genome 7
AB_02178 Interactor 165 AB_01647 Interactor 165 AB_02252 Interactor 165 AB_02372 Genome 7
DC AB_03493 VaC 84 AB_01641 Interactor 165 AB_01491 Interactor 165 AB_01641 Genome 165
AB_01517 VaC 84 AB_02522 Interactor 165 AB_01641 Interactor 165 AB_03207 Genome 165
AB_01255 Interactor 165 AB_03351 ViF 165 AB_00239 KeF 165 AB_03659 Genome 165
AB_03704 VaC 108 AB_00353 ViF 163 AB_03022 Interactor 165 AB_03512 Genome 165
AB_00353 VaC 163 AB_01947 Interactor 165 AB_02437 KeF 165 AB_03532 Genome 165
AB_01334 VaC 165 AB_03184 Interactor 165 AB_01461 KeF 165 AB_01740 Genome 165
AB_00811 Interactor 124 AB_02069 Interactor 165 AB_01350 Interactor 165 AB_01651 Genome 165
AB_02146 Interactor 112 AB_02627 Interactor 165 AB_01047 Interactor 165 AB_02576 Genome 165
AB_00805 Interactor 104 AB_03186 Interactor 165 AB_03233 Interactor 165 AB_03046 Genome 165
AB_03351 Interactor 165 AB_02909 Interactor 165 AB_03046 Interactor 165 AB_01461 Genome 165
AB_02233 VaC 165 AB_01226 Interactor 165 AB_02576 KeF 165 AB_03233 Genome 165
AB_03186 Interactor 165 AB_00660 Interactor 165 AB_02252 Interactor 165 AB_01491 Genome 165
AB_03184 Interactor 165 AB_02910 Interactor 165 AB_01051 Interactor 165 AB_00091 Genome 165
AB_03185 Interactor 165 AB_02683 ViF 165 AB_01740 Interactor 165 AB_00045 Genome 74
AB_01388 VaC 102 AB_01361 Interactor 165 AB_00091 KeF 165 AB_01281 Genome 165
EC AB_01255 Interactor 165 AB_02627 Interactor 165 AB_01491 Interactor 165 AB_02522 Genome 165
AB_02233 VaC 165 AB_02354 Interactor 165 AB_03022 Interactor 165 AB_02769 Genome 165
AB_03186 Interactor 165 AB_02629 Interactor 165 AB_02437 KeF 165 AB_03233 Genome 165
AB_03184 Interactor 165 AB_01950 Interactor 165 AB_01461 KeF 165 AB_00091 Genome 165
AB_03185 Interactor 165 AB_03765 Interactor 165 AB_01350 Interactor 165 AB_03207 Genome 165
(Continued)
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TABLE 3 | Continued
Centrality
measures
Protein ID Protein
type
Core Protein ID Protein type Core Protein ID Protein
type
Core Protein ID Protein
type
Core
AB_01226 Interactor 165 AB_00169 Interactor 165 AB_01047 Interactor 165 AB_01641 Genome 165
AB_02909 Interactor 165 AB_01359 Interactor 165 AB_03233 Interactor 165 AB_03022 Genome 165
AB_02910 Interactor 165 AB_01360 Interactor 165 AB_03046 Interactor 165 AB_02437 Genome 165
AB_01257 Interactor 163 AB_01656 Interactor 165 AB_02576 KeF 165 AB_01350 Genome 165
AB_00660 Interactor 165 AB_01791 Interactor 156 AB_02252 Interactor 165 AB_01047 Genome 165
AB_00760 Interactor 153 AB_01948 ViF 165 AB_01051 Interactor 165 AB_01461 Genome 165
AB_01258 Interactor 153 AB_01951 Interactor 165 AB_01740 Interactor 165 AB_00239 Genome 165
AB_02683 Interactor 165 AB_02545 Interactor 165 AB_00091 KeF 165 AB_03512 Genome 165
AB_00675 Interactor 165 AB_02548 Interactor 165 AB_01789 KeF 165 AB_01491 Genome 165
AB_02914 Interactor 165 AB_02626 Interactor 165 AB_03031 Interactor 165 AB_01051 Genome 165
Shades of green in light are for interactors while those in dark are the candidates from each category.
sorting of the whole genome proteins as per the four centrality
measures yielded 2, 0, 14, and 15, respectively, of which 0, 0, 4,
and 2 proteins, respectively, belong to either the VaC, ViF, or KeF
category while the rest are their interactors (Table 3).
Furthermore, to identify the candidate VaC, ViF, and KeF
proteins in the network topological space of A. baumannii, we
have classified the protein sets of GPIN and represented them
cartographically (Figure 5; Supplementary Data 4). Essentially,
one part of such classification, namely, z score, is based on their
regional connectivity with other similar proteins having a similar
biological function, which is referred to as the functional module.
The other part, namely, the participation coefficient, P, deals
with the participation of these proteins with other functional
modules, either related or non-related. Thus, there are seven such
quadrants that are formed and termed R1 to R7. Noticeably, the
proteins of VaCAB and ViFAB are spread throughout R1–R3 in
the network space, while those of KeFAB are mostly concentrated
in R5 (Figure 5; Supplementary Data 4). Interestingly, R4 and
R6 did not show any mapping of the VaC, ViF, or KeF
proteins or their interactors, represented by V, F, and K
comprising the full VaCAB, ViFAB, and KeFAB SPIN (Figure 5;
Supplementary Data 4). Furthermore, there were no proteins
from the GPIN that occupied the R7 quadrant, having the highest
P or z scores. With a more focused analysis to find out the
most indispensable proteins of GPIN, we have performed the
KFC method mentioned by Ashraf et al. (2018). These KFC
proteins all belong to the innermost 165th core and had R5 as
their classifying P vs. z quadrant and high EC scores (Table 3;
Supplementary Data 4).
The Candidature Prediction
To ascertain the plausible candidature of the proteins of VaCAB,
ViFAB, KeFAB, and GPIN as either vaccine or drug targets, we
have reclassified them as VaC, ViF, and KeF, along with their
interactors and KFC proteins, as mentioned in the previous
section. This projects 2 VaC with 13 interactors, 4 ViF with 29
interactors, 19 KeF with 41 interactors from the 165th core and
10 KFC proteins for further analyses (Tables 3, 4). Among these,
the cellular localization could not be determined for one VaC,
two ViF, five KeF, and two R6 proteins, respectively. Notably,
one candidate fromVaC, namely, AB_02233, belongs to the outer
membrane, while the periplasmic and extracellular comprise the
ViF category. The remaining categories of KeF, KFC, and R6
mostly comprise cytoplasmic proteins having few cytoplasmic
membrane proteins for KeF and R6 as well (Table 7). To this end,
only one KeF (AB_01691) did not reflect any COG classification
for the aforementioned categories. On the contrary, 50% of
R6 proteins did not reflect any COG, being uncharacterized.
Interestingly, only one protein from each of the VaC, ViF, and
KeF categories, namely, AB_02233, AB_03351, and AB_01758,
respectively, predicted a signal peptide while KFC and R6 did
not show any. Moreover, only one lipoprotein cleavage site was
predicted for ViF, KeF, and R6, namely, AB_03351, B_01758, and
AB_00641, respectively, while VaC has two proteins (AB_01334
and AB_02233) showing the same compared to KFC, having
none. Furthermore, about 50% of the proteins of the category
KeF and KFC indicated an overlap of the antigenic site with the
active pocket site while proteins of VaC, ViF, and R6 had no such
overlap for candidature prediction (Table 7).
The Final Selection
Finally, to assess for the relevance of the final set of proteins
(Table 4), in virulence and pathogenicity of Acinetobacter, we
have cross-examined through UniProt, PDB, and PubMed,
for their role, either predictive or empirical, in Acinetobacter
and/or other gram-negative bacterial pathogens. Two unique
VaC proteins, namely, AB_01334 and AB_02233, are predicted
to encode tetratricopeptide repeat protein and peptidase M16
inactive domain protein, respectively (Table 7). Annotations
for other ViF proteins like thiol:disulfide interchange protein
(AB_03351), malate dehydrogenase (AB_02683), and 50S
ribosomal protein L7/L12 (AB_01948) were inferred from
homology while AB_01731 was experimentally verified to have
the function of a nucleoside diphosphate kinase (Table 7). The
KeF proteins are shown to be a conglomerate of different
types engaged in different biological process starting from
carbohydrate, amino acid, and DNA metabolism to even
those involved in signal transduction, cell wall synthesis,
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TABLE 4 | The candidate proteins of VaC, ViF, KeF, and KFC along with their interactors in A. baumannii ATCC19606 strain.
Category VaCAB ViFAB KeFAB KFC
Protein type VaC Interactors ViF Interactors KeF Interactors
AB_01334 AB_00660 AB_03351 AB_00169 AB_03689 AB_01249 AB_02522
AB_02233 AB_00675 AB_01731 AB_00660 AB_03360 AB_01784 AB_02769
AB_01226 AB_02683 AB_01226 AB_03276 AB_03688 AB_03233
AB_01255 AB_01948 AB_01248 AB_03274 AB_03695 AB_00091
AB_02178 AB_01255 AB_03221 AB_03697 AB_03207
AB_02683 AB_01359 AB_03191 AB_03371 AB_01641
AB_02909 AB_01360 AB_02008 AB_03354 AB_03022
AB_02910 AB_01361 AB_01991 AB_03349 AB_02437
AB_02914 AB_01641 AB_01903 AB_03269 AB_01350
AB_03184 AB_01647 AB_01875 AB_03268 AB_01047
AB_03185 AB_01656 AB_01854 AB_03266
AB_03186 AB_01946 AB_01851 AB_03257
AB_03351 AB_01947 AB_01810 AB_03245
AB_01950 AB_01791 AB_03244
AB_01951 AB_01758 AB_03209
AB_02069 AB_01757 AB_02016
AB_02124 AB_01723 AB_01961
AB_02354 AB_01691 AB_01953
AB_02522 AB_01682 AB_01952
AB_02545 AB_01931
AB_02548 AB_01899
AB_02626 AB_01885
AB_02627 AB_01876
AB_02629 AB_01868
AB_02909 AB_01834
AB_02910 AB_01829
AB_03184 AB_01817
AB_03186 AB_01816
AB_03765 AB_01796
AB_01794
AB_01793
AB_01787
AB_01784
AB_01755
AB_01734
AB_01733
AB_01725
AB_01721
AB_01720
AB_01711
AB_01665
VaC, ViF, KeF, and KFC denote Vaccine candidates, Virulent Factors, Key Factors, and K-core-Functional modularity-Centrality, respectively. The prefix of the accession numbers for the
proteins has been replaced by AB.
ribosomal and translational machineries, as well as some
uncharacterized proteins (AB_02008 and AB_01691; Table 7).
On the contrary, proteins of the KFC class are only concentrated
on carbohydrate, amino acid, and fatty acid metabolism with the
inclusion of one (AB_01641) having DNA polymerase with 5′-
3′ exonuclease activity. Again, proteins of the R6 category are
mostly either uncharacterized or belong to the transcriptional
regulator family with the inclusion of one CRISPR-associated
protein (AB_01430).
All the corresponding candidates from ATCC19606 have been
mapped onto ATCC17978 and AYE strains of A. baumannii as
reflected in Table 5 for the ease of use by future researchers.
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TABLE 5 | Corresponding candidates of A. baumannii ATCC19606 in
ATCC17978 and AYE strains.
STRAIN_19606 STRAIN_AYE STRAIN17978
VaC HMPREF0010_01334 ABAYE2977 –
HMPREF0010_02233 ABAYE0990 –
ViF HMPREF0010_03351 ABAYE3833 –
HMPREF0010_01731 ABAYE3267 –
HMPREF0010_02683 ABAYE0465 –
HMPREF0010_01948 ABAYE3490 –
KeF HMPREF0010_03689 – A1S_0003
HMPREF0010_03360 – A1S_0028
HMPREF0010_03276 – A1S_0061
HMPREF0010_03274 – A1S_0063
HMPREF0010_03221 – A1S_0114
HMPREF0010_03191 – A1S_0147
HMPREF0010_02008 – A1S_0217
HMPREF0010_01991 – A1S_0236
HMPREF0010_01903 – A1S_0334
HMPREF0010_01875 – A1S_0364
HMPREF0010_01854 – A1S_0388
HMPREF0010_01851 – A1S_0391
HMPREF0010_01810 – A1S_0428
HMPREF0010_01791 – A1S_0447
HMPREF0010_01758 – A1S_0469
HMPREF0010_01757 – A1S_0470
HMPREF0010_01723 – A1S_0506
HMPREF0010_01691 – A1S_0561
HMPREF0010_01682 – A1S_0571
KFC HMPREF0010_02522 – –
HMPREF0010_02769 – –
HMPREF0010_03233 – –
HMPREF0010_00091 – A1S_2232
HMPREF0010_03207 – –
HMPREF0010_01641 – –
HMPREF0010_03022 – –
HMPREF0010_02437 – A1S_3280
HMPREF0010_01350 – –
HMPREF0010_01047 – –
Moreover, to determine the orthologous presence of these
proteins in the human host, their pairwise identities (PI) and
query coverages (QC) are reflected in Table 6. Notably, the VaC
proteins have considerably low PI and QC, which is exactly
opposite in nature to all but one of the proteins of KFC, having
high QC and PI. Intriguingly, ViF, KeF, and R6 comprise a
mixture of unique proteins having no human counterpart as well
as those having moderate to high PI. Of these, however, only
proteins of ViF have very high QC as well (Table 6).
DISCUSSION
The sole aim of this study is to look out for plausible vaccine
and/or drug candidates among a plethora of proteins from
TABLE 6 | The human counterparts of the corresponding VaC, ViF, KeF, KFC, and
R6 candidates of A. baumannii ATCC19606 strain.
Modified String_ID Accession_ID Query coverage Identity
VaC AB_01334 NP_858059.1 29% 26%
AB_02233 NP_004270.2 25% 23%
ViF AB_03351 – – –
AB_01731 NP_002504.2 95% 50%
AB_02683 NP_005908.1 98% 52%
AB_01948 – – –
KeF AB_03689 XP_016869997.1 13% 35%
AB_03360 – – –
AB_03276 – – –
AB_03274 – – –
AB_03221 – – –
AB_03191 – – –
AB_02008 – – –
AB_01991 – – –
AB_01903 XP_006712602.1 27% 36%
AB_01875 NP_008965.2 95% 32%
AB_01854 – – –
AB_01851 – – –
AB_01810 XP_011511104.1 11% 39%
AB_01791 – – –
AB_01758 XP_005268046.1 60% 43%
AB_01757 XP_005273641.1 51% 33%
AB_01723 NP_001182351.1 27% 26%
AB_01691 – – –
AB_01682 NP_001177809.1 96% 33%
KFC AB_02522 XP_024303263.1 3% 43%
AB_02769 XP_016866853.1 100% 83%
AB_03233 NP_005580.1 94% 61%
AB_00091 NP_005580.1 90% 47%
AB_03207 XP_016862911.1 98% 36%
AB_01641 NP_861524.2 50% 32%
AB_03022 NP_001193826.1 97% 38%
AB_02437 NP_001071.1 95% 53%
AB_01350 NP_001071.1 98% 50%
AB_01047 NP_001071.1 98% 55%
R6 AB_00210 –
AB_00797 NP_060206.2 10% 41%
AB_03124 – – –
AB_02872 – – –
AB_02571 – – –
AB_00406 – – –
AB_00641 – – –
AB_01430 NP_005236.2 12% 36%
AB_01223 – – –
AB_01974 – – –
VaC, ViF, KeF, and KFC denote Vaccine candidates, Virulent Factors, Key Factors, K-core-
Functional modularity-Centrality and Function-R6, respectively. The prefix of the accession
numbers for the proteins has been replaced by AB.
the whole genome of A. baumannii. In this context, the work
proposed by Moriel et al. (2013) has mentioned an array
of proteins as candidates for vaccines to test out in real-
life scenario. Besides these, several researchers have proposed
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different virulence factors crucial for the XDR A. baumannii,
probably potential enough to be targeted as drugs. Moreover, the
VFDB presents lists of several such factors as well. Considering
a filtration to shortlist just few of these would probably be a
good idea to save the time and money of future researchers in
this field of study. Thus, network analysis is being considered in
order to sort and identify, albeit theoretically, the most probable
candidates among them.
With the target being set out for the pathogenic strains like
AYE and ATCC17978, themain hindrance was the lack of protein
interaction datasets for these strains in the STRING database.
This led to the mapping of the proteins from these strains onto
ATCC19606. We started with an initial categorization of the
protein sets proposed by Moriel et al. (2013) based on their
results. One set, representing theA. baumannii antigenic proteins
identified through reverse vaccinology approach, was denoted as
Vaccine Candidates (VaC). The other set was named Virulence
Factors (ViF) and comprised all other proteins listed by the same
group including OMVs and secretome, potentially insoluble
proteins and periplasmic proteins found in OMV and secretome
of A. baumannii. Initial filtration through standalone BLAST
led to almost the same number of proteins in ATCC19606.
A stringent filtering approach with 99–100% identity cutoff
threshold, however, was adopted to rule out any ambiguity of
the protein functions upon such conversion from the former
strains to the latter. Similar strategies were adopted for database-
and literature-retrieved proteins searched through keywords and
were named Key Factors (KeF).
As the proteins would always be interacting with others to
manifest their functions, a PIN construction was the next move
for the VaC, ViF, and KeF protein sets to yield the three SPINs
namely, VaCAB, ViFAB, and KeFAB. These were analyzed for
their importance through the four centrality parameters BC, CC,
DC, and EC, often utilized for biological network analysis (Jeong
et al., 2001; Lahiri et al., 2014; Pan et al., 2015; Pawar et al.,
2017, 2018; Ashraf et al., 2018). Among them, DC reflects the
simple network connectedness of any protein, while for a virulent
phenotype, CC might bring out the functional proximity of a
protein with others. Moreover, BC might help in reflecting the
bridging of different functionally important groups of virulent
proteins, thereby posing its importance to be targeted for
therapeutic purposes. EC, however, might reflect the connectivity
of the most important proteins with other important proteins in
a virulent network, thereby posing them to be indispensable for
therapeutic targets. Notably, there were overlaps between VaC
andViF categories of proteins across different centralitymeasures
(Table 2), probably indicating a faint line of difference between
them, which actually were set by this study and not by Moriel
et al. (2013). Moreover, there were very few overlaps of VaC
and ViF proteins with those of KeF sets, probably indicating the
uniqueness of the former groups compared to the common KeF
proteins already reported in the literature and database searched
through keywords (Table 2).
The functional aspects of the candidate proteins would be
best put forward through the whole genome global scenario
for which the GPIN was constructed (Figure 2D) and analyzed
by the network centrality and other topological parametric
measures (Supplementary Data 4). The initial characterization
of the GPIN was done through the exponential decay of the
degree distribution, P(k), of a particular node upon connecting
to k other nodes, for large values of k. Such construction at
least confirms the non-random (Erds and Rényi, 1960) or non-
small-world nature (Watts and Strogatz, 1998) of the GPIN, if
not completely following the power law (Albert et al., 2000)
and becoming scale free (Figure 4A). Hereafter, the constructed
GPIN is analyzed with the four centrality measures. Proteins of
KeFAB categories occupying most of the EC and DC measures
probably indicate the importance of either of these measures
in bringing out the top rankers of KeFAB proteins (Table 2).
Moreover, with no appearance among the top 15 important
categories, the VaCAB and ViFAB proteins might not be so
essential from the whole genome perspective (Table 2).
The actual set of proteins important from the GPIN
perspective are probably reflected by the innermost core of
the proteins brought about by the k-core/K-shell topological
parameters (Figures 4B,C). The concept of the importance of
the innermost k-core lies in the fact that k-core is a subnetwork
with a minimum number of k-links such that the 165th
innermost core would have 165 connections of each of those
proteins lying in that core (Figure 4B; Supplementary Data 4).
Essentially, the number of proteins in this case is 498 (Figure 4C;
Supplementary Data 4). With such a large inner core member
proteins having high connectivity, the core tends to be highly
interactive and, thus, robust in nature (Alvarez-Hamelin et al.,
2005). This could be indicative of the tight control resistance
mechanism of this MDR/XDR species of A. baumannii. It is
important to note that the relation between a K-shell and k-core
is that the former is the part of the latter but not of the (k + 1)-
core, such that the former is a set of nodes having exactly k-links.
This brings out the fact that there are a lower number of proteins
(interacting among their partners) with lower k-core that belongs
to the outer shell, and thus, the innermost core would have
the maximum number of proteins needed to be decomposed to
affect the global network of A. baumannii. Interestingly, only
limited VaC and ViF proteins (2 and 4, respectively) belong
to the 165th innermost core identified through all different
centrality measures (Table 3). These numbers are 12–13% of the
total proteins of VaCAB and ViFAB including the VaC and ViF
proteins along with their interactors. In comparison to these,
∼32% of the total proteins of KeFAB are important as KeF
(Table 3). These probably tells us that only few proteins are
important from VaC and ViF compared to KeF categories. Thus,
considering just these few proteins as either vaccines or drug
targets may not be sufficient to break the robust inner core
compared to a large number of options available for KeF proteins.
With some preliminary idea about the centrality and k-
core measures, we moved on to delve deep into the functional
connectivity, R, of the modules formed in the GPIN. Such
connectivity of the proteins within and between the functional
modules is represented cartographically by P-values and z score,
respectively, across the x- and y-axis. This results in the lowest
values of P and z for R1 and the highest for R7. The classifications
are thus named ultra-peripheral proteins (R1) and peripheral
proteins (R2), which can be detached with convenience from
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TABLE 7 | Protein analyses of selected VaC, ViF, KeF, and KFC proteins of A. baumannii for cellular localization, COG classification, antigenicity, and active site predictions.
String-
id
Protein description:
function
Localization COG analysis Cleavage position Epitope analysis Active site
analysis
PSORTb Accession Name SignalP LipoP Peptide Start End length
VaCAB
AB_01334 Tetratricopeptide
repeat protein: DNA
binding
Unknown COG5010 TadD 32,N 31–32 KHANDPQL 547 554 8 511–523
AB_02233 Peptidase M16 inactive
domain protein: metal
ion binding;
metalloendopeptidase
activity
Outer
Membrane
COG0612 PqqL 24,Y 23–24 KDKPKTLDQTDVKAEPLKDPKVY 454 476 23 404–442
ViFAB
AB_03351
Thiol:disulfide
interchange protein
protein disulfide
oxidoreductase activity
Periplasmic COG1651 DsbG 23,Y 22–23 GKVEVP 38 43 6 67–81
QGEDGK 184 189 6
AB_01731 Nucleoside
diphosphate kinase:
ATP binding; metal ion
binding; nucleoside
diphosphate kinase
activity
Extracellular COG0105 Ndk 48,N – NAAHGSDSVAS 114 124 11 104–128
AB_02683 Malate dehydrogenase:
L-malate
dehydrogenase activity
Unknown COG0039 Mdh 28,N – GESLKDKINDPAW 204 216 13 225–244
AB_01948 50S ribosomal protein
L7/L12: structural
constituent of ribosome
Unknown COG0222 RplL 51,N – APAGGAAAAAEEQSE 42 56 15 38–50
KeFAB
AB_03689 DNA replication and
repair protein RecF:
ATP binding;
single-stranded DNA
binding
Cytoplasmic COG1195 RecF 30,N – DPQSTDI 114 120 7 112–165
AB_03360 Alkanesulfonate
monooxygenase:
alkanesulfonate
monooxygenase
activity
Cytoplasmic COG2141 COG2141 37,N – TWGEPPAAV 198 206 9 140–172
ALVGDPETV 306 314 9 356–365
AB_03276 Bacterial sugar
transferase: transferase
activity, transferring
glycosyl groups
Cytoplasmic
Membrane
COG2148 WcaJ 30,N – FDAQGNPLPDEARI 66 79 14 42–97
(Continued)
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TABLE 7 | Continued
String-
id
Protein description:
function
Localization COG analysis Cleavage position Epitope analysis Active site
analysis
PSORTb Accession Name SignalP LipoP Peptide Start End length
AB_03274 UDP-glucose
6-dehydrogenase: NAD
binding; UDP-glucose
6-dehydrogenase
activity
Cytoplasmic COG1004 Ugd 17,N – KENTSSTHN 307 315 9 306–399
AB_03221 Phosphopantetheine
attachment domain
protein:
phosphopantetheine
binding
Unknown COG0236 AcpP 25,N – PETIDPDQKF 24 33 10 32–67
AB_03191 ATP synthase F0, I
subunit: hydrolase
activity
Cytoplasmic
Membrane
COG3312 AtpI 31,N – AR 67 68 2 68–74
AB_02008 Uncharacterized
protein
Unknown COG2960 COG2960 55,N – DEPKKD 14 19 6 32–43
AB_01991 Response regulator
receiver domain
protein: DNA binding
Cytoplasmic COG2197 CitB 26,N – SDTQQSPFDS 139 148 10 131–174
AB_01903 Ribosome maturation
factor RimP: Required
for maturation of 30S
ribosomal subunits
Cytoplasmic COG0779 COG0779 21,N – PVDENAEPVINEDGEVEQG 46 64 19 60–61
AB_01875 DnaJ domain protein
unfolded protein
binding+C4
Cytoplasmic COG0484 DnaJ 62,N – GFGGGQQQYQRQ 117 128 12 101–195
AB_01854 S-
(Hydroxymethyl)glutathione
synthase: carbon-sulfur
lyase activity
Unknown COG3791 COG3791 46,N – TPLDQK 104 109 6 72–115
AB_01851 50S ribosomal protein
L31 type B: structural
constituent of ribosome
Cytoplasmic COG0254 RpmE 20,N – QTKQTKEYQG 30 39 10 40–41
AB_01810 Endonuclease/
exonuclease/
phosphatase family
protein: endonuclease
activity; exonuclease
activity
Cytoplasmic COG3021 COG3021 23,N – PKPPSPTEAKDSTL 208 221 14 245–291
AB_01791 50S ribosomal protein
L33: structural
constituent of ribosome
Cytoplasmic COG0267 RpmG 21,N – KNKRTM 21 26 6 22–31
AB_01758 Sel1 repeat protein Unknown COG0790 COG0790 21,Y 20–21 ASNGDNR 120 126 7 97–129
(Continued)
F
ro
n
tie
rs
in
C
e
llu
la
r
a
n
d
In
fe
c
tio
n
M
ic
ro
b
io
lo
g
y
|w
w
w
.fro
n
tie
rsin
.o
rg
1
6
Ju
n
e
2
0
1
9
|V
o
lu
m
e
9
|
A
rtic
le
2
0
3
M
u
ja
w
a
r
e
t
a
l.
V
a
c
c
in
e
C
a
n
d
id
a
te
s
a
n
d
D
ru
g
Ta
rg
e
ts
o
f
A
.
b
a
u
m
a
n
n
ii
TABLE 7 | Continued
String-
id
Protein description:
function
Localization COG analysis Cleavage position Epitope analysis Active site
analysis
PSORTb Accession Name SignalP LipoP Peptide Start End length
AB_01757 Methionine
biosynthesis protein
MetW
Cytoplasmic COG2226 UbiE 31,N – IK 12 13 2 8–18
NQ 72 73 2 81–84
AB_01723 GTPase Der: GTP
binding
Cytoplasmic
Membrane
COG1160 COG1160 31,N – SENPFEGRKSQVDERTA 434 450 17 119–150
AB_01691 Uncharacterized
protein
Unknown NA NA 21,N – TMKPNNHSTETNTPPAI 36 52 17 69–74
AB_01682 AP endonuclease,
family 2: endonuclease
activity; isomerase
activity
Cytoplasmic COG3622 Hfi 29,N – PGRHEPDTAQI 211 221 11 206–242
KFC
AB_02522
Glutamate synthase
[NADPH], large subunit:
glutamate synthase
(NADPH) activity
Cytoplasmic COG0067 GltB 60,N – GRSNSGEGGEDPARY 896 910 15 867–996
COG0069 GltB
COG0070 GltB
AB_02769 Putative fatty acid
oxidation complex
subunit alpha:
3-hydroxyacyl-CoA
dehydrogenase activity;
lyase activity
Cytoplasmic COG1250 FadB 26,N – YKIPGGDPKTPA 216 227 12 239–297
AB_03233 Methylmalonate-
semialdehyde
dehydrogenase
(Acylating):
methylmalonate-
semialdehyde
dehydrogenase
(acylating) activity
Cytoplasmic COG1012 PutA 70,N – GKTLADAEGD 106 115 10 141–147
AB_00091 Methylmalonate-
semialdehyde
dehydrogenase
(Acylating):
methylmalonate-
semialdehyde
dehydrogenase
(acylating) activity
Cytoplasmic COG1012 PutA 44,N – ARKQPVYNPATGEIS 41 55 15 140–145
(Continued)
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TABLE 7 | Continued
String-
id
Protein description:
function
Localization COG analysis Cleavage position Epitope analysis Active site
analysis
PSORTb Accession Name SignalP LipoP Peptide Start End length
AB_03207 GMP synthase
[glutamine-hydrolyzing]:
ATP binding; GMP
synthase
(glutamine-hydrolyzing)
activity;
pyrophosphatase
activity
Cytoplasmic COG0518 GuaA 23,N – GPESVHEEGSPRA 61 73 13 60–92
COG0519 GuaA
AB_01641 DNA polymerase I:
3′-5′ exonuclease
activity; DNA binding;
DNA-directed DNA
polymerase activity
Cytoplasmic COG0749 PolA 20,N – VKPAQTIETEDQASLTSQDDQLG 303 325 23 599–687
AB_03022 Putative
aminobutyraldehyde
dehydrogenase:
oxidoreductase activity,
acting on the aldehyde
or oxo group of donors,
NAD or NADP as
acceptor
Cytoplasmic COG1012 PutA 36,N – EVYAQSPNATEAEV 32 45 14 33–97
AB_02437 Succinate-
semialdehyde
dehydrogenase
[NAD(P)+]: succinate-
semialdehyde
dehydrogenase
[NAD(P)+] activity
Cytoplasmic COG1012 PutA 61,N – DGRQEGSTQGPLI 318 330 13 330–386
AB_01350 Succinate-
semialdehyde
dehydrogenase
[NAD(P)+]: succinate-
semialdehyde
dehydrogenase
[NAD(P)+] activity
Cytoplasmic COG1012 PutA 38,N – NATVPVSNPATGEEIG 26 41 16 59–73
(Continued)
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TABLE 7 | Continued
String-
id
Protein description:
function
Localization COG analysis Cleavage position Epitope analysis Active site
analysis
PSORTb Accession Name SignalP LipoP Peptide Start End length
AB_01047 Succinate-
semialdehyde
dehydrogenase
[NAD(P)+]: succinate-
semialdehyde
dehydrogenase
[NAD(P)+] activity
Cytoplasmic COG1012 PutA 16,N – GLGREGSKY 459 467 9 410–476
R6
AB_00210 Uncharacterized
protein
Unknown COG2911 COG2911 21,N – VEQQPTSAPSSPK 4 16 13
AB_00797 Transcriptional
regulator, TetR family:
DNA binding
Cytoplasmic COG1309 AcrR 39,N – EKA 78 80 3
AB_03124 Putative phage
uncharacterized protein
domain protein
Cytoplasmic
Membrane
COG5412 COG5412 40,N – DPTKPIEPPKPPKLGL
GTAPPNPKLGIGTGE
KDDKGGSKSSAKS
KAEQEAKERQRQAEQ
494 552 59 587–599
AB_02872 Uncharacterized
protein
Cytoplasmic NA NA 45,N – QQHAGESVKKNRKAQSIKS
GYDESAEQSVELEED
FEQYAAEQQQAR
EQAKQQRQQQKREQAEQM
122 185 64 65–89
AB_02571 Uncharacterized
protein
Cytoplasmic NA NA 42,N – SIDPEQVED 118 126 9
QQAENPKKG 294 302 9
AB_00406 Uncharacterized
protein
Cytoplasmic
Membrane
NA NA 11,N – SGSARPGFS 139 147 9 57–136
AB_00641 Uncharacterized
protein
Cytoplasmic NA NA 23,N 17–18 AEEKPTEKTEKTS
TIKATEQPPKEEN
22 47 26 16–97
AB_01430 CRISPR-associated
protein, Csy2 family
Unknown NA NA 32,N – RQAQDQENTAHA 227 238 12 110–178
AB_01223 Transcriptional
regulator, TetR family:
DNA binding
Cytoplasmic COG1309 AcrR 33,N – ESNQDDQ 131 137 7
AB_01974 Transcriptional
regulator, TetR family:
DNA binding
Cytoplasmic COG1309 AcrR 11,N – EFPANSSERSSVKQ 112 125 14
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the network. Moreover, the non-hub connectors (R3) might be
involved in connecting fundamental sets of interactions while
the non-hub kinless proteins (R4) connect other proteins evenly
distributed across the modules without forming hubs themselves.
Furthermore, the provincial hub proteins, R5, have many within-
module connections, whereas the connector hubs, R6 proteins
connect most of the other modules, and thus are probably most
conserved in terms of decomposition as well as evolution. Finally,
the kinless hubs, R7 proteins, show the highest connection within
and between the members of the GPIN such that they could be
the most essential ones to be maintained by the pathogen for
its very survival. Taking into account the importance of such
functional modules, we have sorted the GPIN as per the KFC
method adopted by Ashraf et al. (2018). We found the 165th core
getting aligned with the functional module R5 proteins having
the highest EC values (Table 3; Supplementary Data 4: Sheet 2).
With a consolidated set of VaC, ViF, KeF, and KFC proteins,
we have set our ultimate goal to determine their antigenic
potential and predicted some probable active sites. As cellular
location plays an important role in conferring the potential of
proteins as vaccines and/or drugs, we have attempted for the
same and identified the COG classes for them, keeping in view the
uncharacterized proteins taken as reference for the R6 categories.
Interestingly, most of the proteins of VAC, ViF, KeF, and KFC
could be classified as per COG, suggesting their likelihood to
share similar functions. To this end, the antibody epitope site
prediction shared 50% similarities with the predicted active sites
of the validated homology modeled structures of KeF and KFC
proteins, suggesting their plausibility to be used either as vaccine
candidates or as drug candidates. On the contrary, VaC, ViF,
and R6 proteins were unique enough and would probably have
to be experimentally verified for their actual candidature. All
such VaC, ViF, KeF, and KFC proteins were mapped back from
ATCC19606 strains to the strains of AYE or ATCC17978 for the
ease of quick referral for future researchers (Table 5). Besides
the aforementioned list in Table 4, a comparison of the proteins
with their Homo sapiens counterpart has been made as reflected
in Table 6. This was done to ensure that the proteins of A.
baumannii are different from their host, either fully or largely,
and thus could be used as targets.
A comparison of the data from Tables 6, 7 shows that the
protein with the accession ID AB_02233 is a good candidate for
vaccine, residing on the outer membrane, having a signal peptide,
and bearing much less similarity with its human counterpart.
Similarly, the protein AB_03351 is a good candidate for drugs,
having periplasmic location, a signal peptide, and no match at
all with the human host proteins. A very difficult comparison
is posed for the KeF proteins, which largely present themselves
as either cytoplasmic or cytoplasmic membrane. The protein
with the accession number AB_01758 could have some potential
though its similarity with the human counterpart rules out
such possibility. Proteins of the KFC category, surprisingly,
do not present themselves as good candidates at all, all being
cytoplasmic, having no signal peptides, and bearing huge
similarity with their human homologs. The protein AB_02522
in this category having much less query coverage (3%), however,
does not stand a chance either, owing to its cellular localization
in the cytoplasm. Similarly, most cytoplasmic proteins of the
R6 category present themselves as poor candidates for vaccines
and/or drugs. One uncharacterized protein, viz., AB_00210
of unknown cellular localization in this category could be
of some potential due to the absence of any match with
human counterpart.
A completely different approach of interactor-free centrality-
based ranking of the different classes of the candidates proposed
by Moriel et al. (2013) unanimously pulls out AB_00353 from
proteins of the outer membrane class, AB_01731, from those
of the extracellular region and a set of five proteins from
the periplasmic region category (Supplementary Data 5).
Among these, the protein AB_00353 or BamA has already
been found by some in silico approach earlier and reported to
elicit high IgG antibody titer with the production of opsonizing
antibodies against a virulent MDR clinical isolate using a murine
pneumonia model (Singh et al., 2017). The other protein,
AB_01731, coding for nucleoside diphosphate kinase, has also
been reported by another group through reverse vaccinology
approach (Chiang et al., 2015). Of the five periplasmic proteins,
HMPREF0010_03351 (Supplementary Data 5) (reflected as
AB_03351 in Table 7) has been found out by our detailed
interactome-based approach as well. These proteins have
the potential to be used as either vaccine candidates, for the
outer membrane proteins, or drugs, for other periplasmic or
cytoplasmic proteins. Unknown or uncharacterized proteins
from different aforementioned categories (Table 7), however,
can be worked upon by future researchers for more prospective
candidates as well. Thus, a mixed-bag result has come out
of the analyses done through our two approaches. Of the
interactome-based approach, where the interactors have been
considered as well, the actual candidates were sorted through
network centrality and protein signature analyses and the
results need to be further experimentally validated as most of
the candidates are novel and not reported earlier. The other,
interactor-free approach, considered the candidates from their
cellular localization and network centrality analyses unanimously
bring out two candidates already reported earlier. The success of
future researchers in targeting a protein for vaccine candidates
and/or drugs would, thus, depend on further experimental
validation for any category of proteins.
CONCLUSION
The study is based on the concept of utilizing the already
proclaimed vaccine candidates and virulent and other key
pathogenic factors to sort and filter them to a useful list of
most probable final candidates. Essentially, the work revolved
around a network biological approach of analyzing the conceived
networks of the aforementioned proteins and mapping them
onto the whole genome perspective to shortlist the candidates.
To this end, established methods of antigenicity and active site
prediction have been added to produce the final list for further
experimental validation.
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